Many patients with neurologic disorders like multiple sclerosis, epilepsy, and Parkinson disease have seen steep increases in their out-of-pocket costs for drugs in recent years, a US study suggests.
Many patients with neurologic disorders like multiple sclerosis, epilepsy, and Parkinson disease have seen steep increases in their out-of-pocket costs for drugs in recent years, a US study suggests.
Many patients with neurologic...